UltraTech Cement (ULTRACEMCO) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
9 Jan, 2026Executive summary
Q3 FY25 saw a strong recovery in cement demand, with domestic sales volume up 10.5% year-over-year and 9% sequentially, and a 1.4% QoQ increase in realizations, with notable price improvements in North and West regions exceeding 3%.
Major acquisitions included an 8.42% stake in Star Cement (INR 776 crore) and a controlling stake in India Cements, which became a subsidiary effective December 24, 2024, adding 14.45 mtpa grey cement capacity.
UBS retail outlets increased to 4,432, contributing 19.5% of domestic grey sales volume and driving significant sales in Tier-2/3 towns.
Premium product mix rose to 26.5%, up 15% year-over-year.
Integration of Kesoram assets is expected by FY25 year-end, with all project sites progressing well and targeted capacity of 185 million tons by year-end, including acquisitions.
Financial highlights
Consolidated revenues for Q3 FY25 were ₹16,971 crore, up 3% year-over-year and 11% sequentially.
EBITDA per metric ton reached INR 964, up over 30% sequentially from Q2.
PAT was ₹1,470 crore, down 17% year-over-year but up 79% sequentially.
Fuel costs declined to 1.76 kcal from 1.84 per kcal last quarter, with further reduction expected to 1.7 kcal.
Lead distance reduced to 377 km from 400 km, supporting logistics cost savings.
Outlook and guidance
Double-digit volume growth targeted for next year, with capacity utilization expected at 80%-85%.
Industry demand growth projected at 6%-7% for Q4 and double-digit for FY26.
Further price increases anticipated in the coming quarter, with January already seeing a 1.5% rise in Central and West.
Organic growth plans remain on track, with 15.7 mtpa capacity addition in FY25 and 26.5 mtpa planned for FY26 and FY27.
CapEx for FY26 guided at INR 9,000 crore, tapering to INR 6,000-7,000 crore in FY27.
Latest events from UltraTech Cement
- Q1 FY25 delivered 6% volume growth, stable profits, and major capacity expansion amid price softness.ULTRACEMCO
Q1 24/253 Feb 2026 - Q3 FY26 saw double-digit revenue and EBITDA growth, driven by robust demand and expansion.ULTRACEMCO
Q3 25/2624 Jan 2026 - Double-digit growth, capacity expansion, and new ventures drive strong market leadership.ULTRACEMCO
Investor presentation24 Jan 2026 - Leading market share, strong financials, and major expansion drive UltraTech’s growth.ULTRACEMCO
Investor presentation24 Jan 2026 - Q2FY25 profit and sales fell, but expansion, acquisitions, and sustainability advanced.ULTRACEMCO
Q2 24/2519 Jan 2026 - FY25 sales hit ₹74,936 crore, capacity expanded, and a Rs. 77.50 dividend was recommended.ULTRACEMCO
Q4 24/2530 Dec 2025 - Q1 FY26 saw 13% revenue and 49% profit growth, with record capacity and strong sustainability focus.ULTRACEMCO
Q1 25/264 Nov 2025 - Q2FY26 profit jumped 75% YoY on strong volume growth, acquisitions, and cost control.ULTRACEMCO
Q2 25/2620 Oct 2025